UBS Group Raises Xometry (NASDAQ:XMTR) Price Target to $55.00

Xometry (NASDAQ:XMTR) had its target price lifted by investment analysts at UBS Group from $54.00 to $55.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group’s price objective suggests a potential upside of 21.52% from the company’s previous close.

XMTR has been the subject of a number of other reports. Royal Bank Of Canada lowered their price objective on Xometry from $64.00 to $55.00 and set a “sector perform” rating for the company in a research report on Wednesday. JPMorgan Chase & Co. boosted their price target on shares of Xometry from $55.00 to $70.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Zacks Research cut shares of Xometry from a “hold” rating to a “strong sell” rating in a research note on Friday, January 30th. William Blair reiterated an “outperform” rating on shares of Xometry in a research report on Tuesday. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Xometry in a research note on Wednesday, January 21st. Five research analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $62.00.

Xometry Price Performance

XMTR opened at $45.26 on Wednesday. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.76 and a quick ratio of 3.58. The company’s 50 day simple moving average is $61.06 and its 200-day simple moving average is $56.04. Xometry has a one year low of $18.59 and a one year high of $73.87. The stock has a market capitalization of $2.32 billion, a P/E ratio of -37.10 and a beta of 0.86.

Xometry (NASDAQ:XMTR) last posted its quarterly earnings data on Tuesday, February 24th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.04. The firm had revenue of $192.40 million for the quarter, compared to the consensus estimate of $183.37 million. Xometry had a negative return on equity of 5.49% and a negative net margin of 8.99%.The business’s revenue for the quarter was up 29.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.06 EPS. Sell-side analysts anticipate that Xometry will post -0.66 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, President Sanjeev Singh Sahni sold 26,190 shares of the stock in a transaction that occurred on Thursday, January 8th. The stock was sold at an average price of $65.47, for a total transaction of $1,714,659.30. Following the completion of the sale, the president directly owned 63,130 shares of the company’s stock, valued at approximately $4,133,121.10. This represents a 29.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Subir Dutt sold 3,929 shares of the firm’s stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $65.55, for a total transaction of $257,545.95. Following the sale, the insider owned 67,419 shares in the company, valued at $4,419,315.45. This trade represents a 5.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 127,852 shares of company stock worth $6,993,940 in the last three months. 9.66% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Xometry

A number of large investors have recently added to or reduced their stakes in the company. Sylebra Capital LLC lifted its holdings in shares of Xometry by 9.6% in the second quarter. Sylebra Capital LLC now owns 2,062,157 shares of the company’s stock valued at $69,680,000 after purchasing an additional 180,533 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in shares of Xometry by 54.2% in the third quarter. Ameriprise Financial Inc. now owns 1,964,909 shares of the company’s stock valued at $107,029,000 after purchasing an additional 690,558 shares during the last quarter. First Trust Advisors LP lifted its position in shares of Xometry by 9.2% in the fourth quarter. First Trust Advisors LP now owns 1,576,075 shares of the company’s stock worth $93,729,000 after purchasing an additional 132,792 shares in the last quarter. Baillie Gifford & Co. boosted its holdings in Xometry by 1.6% during the fourth quarter. Baillie Gifford & Co. now owns 1,306,151 shares of the company’s stock worth $77,677,000 after purchasing an additional 20,901 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. bought a new position in Xometry in the fourth quarter valued at $76,393,000. Institutional investors own 97.31% of the company’s stock.

More Xometry News

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: UBS raised its price target slightly (from $54 to $55) and kept a neutral rating, signaling modest analyst support for the company’s near‑term outlook. Benzinga: UBS raises PT to $55
• Neutral Sentiment: Xometry published its Q4 2025 earnings call transcript and a CEO succession plan; these releases increase transparency but contain mixed/complex takeaways that investors will parse for guidance and leadership continuity. Yahoo Finance: Xometry Announces CEO Succession Plan Yahoo Finance: Q4 2025 Earnings Transcript
• Negative Sentiment: Multiple senior insiders sold stock on Feb 26 (CEO Randolph Altschuler, CFO James Miln, President Sanjeev Singh Sahni, and director Subir Dutt). The combined sales are large and represent multi‑percentage reductions in their individual holdings, which can be viewed negatively by the market. SEC filings: CEO sale SEC filing CFO sale SEC filing President sale SEC filing Director sale SEC filing
• Negative Sentiment: Several brokerages trimmed price targets: Citigroup cut its target from $75 to $65 (still a buy), Royal Bank of Canada cut from $64 to $55 (sector perform), and Wedbush cut from $70 to $60 (outperform). These downgrades on targets reduce upside expectations and add near‑term pressure. AmericanBankingNews: Citigroup cuts PT to $65 AmericanBankingNews: RBC cuts PT to $55 AmericanBankingNews: Wedbush sets PT to $60

About Xometry

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.